Resources Contact Us Home
Humanized anti-CD70 binding agents and uses thereof

Image Number 17 for United States Patent #8067546.

Disclosed are CD70 binding agents, such as humanized anti-CD70 antibodies and fragments and derivatives, that exert a cytotoxic, cytostatic or immunomodulatory on CD70 expressing cells, as well as pharmaceutical compositions and kits comprising the antibody, fragment or derivative. Also disclosed are methods for the treatment of CD70-expressing cancers and immunological disorders, comprising administering to a subject the CD70 binding agents or pharmaceutical compositions.

  Recently Added Patents
Shoe upper
Monitoring and correcting upstream packet loss
Provision of downlink packet access services to user equipment in spread spectrum communication network
Printing control method and printer for printing on a label
Methods and systems for detecting icing conditions
Variety corn line NPAA2720
Accelerator for a read-channel design and simulation tool
  Randomly Featured Patents
Electronic device
Method and apparatus for battery charge balancing
Method for magnetic resonance imaging
System and detector for measuring by means of sound the liter weight of the material in satellite coolers for rotative ovens
Refreshable scanning tactile graphic display for localized sensory stimulation
Ergonomically curved weapon sling
Esters of 3-tert-butyl- and 3-tert-butyl-5-alkyl-4-hydroxyphenyl (alkane) carboxylic acids with oxyethylates of polythiols
Shoe sole
CMP pad having an overlapping stepped groove arrangement
Utilization of 1-cyclopentenylacetic acid as perfuming ingredient